B-Lymphocytes

Download PDF

Recent Publications on B-Lymphocytes:
Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers. Based on the principle of nonsense-mediated mRNA decay, we sought to...	27th June, 2008	Department of General Surgery, University of Gottingen, Gottingen,	Virchows Arch. 2008 Jun 26;. DOI Direct Link
Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary Chronic Lymphocytic Leukemia to VSV-induced oncolysis. Chronic Lymphocytic Leukemia (CLL) is characterized by clonal accumulation...	27th June, 2008	Molecular Oncology Group, Lady Davis Institute - Jewish General Hospital,	J Virol. 2008 Jun 25;. DOI Direct Link
Expression of bone specific alkaline phosphatase on human B cells. We here report for the first time that human B cell express bone specific...	27th June, 2008	Division of Pediatric Rheumatology/Immunology, Department of Pediatrics,	Cell Immunol. 2008 Jun 23;. DOI Direct Link
Immunoglobulin heavy chain exclusion in the shark. The adaptive immune system depends on specific antigen receptors,...	27th June, 2008	Department of Physiology and Pharmacology, State University of New York	PLoS Biol. 2008 Jun 24;6(6):e157. DOI Direct Link
Targeted Cell Entry of Lentiviral Vectors. Retargeting of lentiviral vector entry to cell types of interest is a key...	26th June, 2008	1Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen,	Mol Ther. 2008 Jun 24;. DOI Direct Link
→View more research publications.

BioNews Results for B-Lymphocytes:
Inflammation, Lipids and Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic st	National AIDS Treatment Advocacy Project:  May 29 2008 12:16AM Matching: b lymphocytes

B-Lymphocytes Clinical Trials:
SAR3419 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)	Lymphoma Intervention: Drug: SAR3419
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma	Lymphoma, Non-Hodgkin;   Lymphoma, B-Cell;   Lymphoma, Diffuse
Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine	Prevention of Meningococcal Infection
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia	Leukemia;   Lymphoma
Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma	Lymphoma;   B-Cell Non-Hodgkin's Lymphoma
→View more trials.

B-Lymphocytes Patents:
US Patent No.	Title
7338761	Detection and quantification of human herpes viruses
7357927	Death domain containing receptors
7358379	Steroid conjugates, preparation thereof and the use thereof
7358416	Transgenic mouse expressing human FcRn protein
7361343	Cytotoxicity mediation of cells evidencing surface expression of CD63
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for B-Lymphocytes scientists - we have details of around 6460 individuals working on B-Lymphocytes .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.